Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Apr 24, 2015 (11 years ago)

Alinia (nitazoxanide)

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Stability Specifications: Product failed to meet 12 months long term stability specification for viscosity

Cause type: Stability / shelf life

The product degraded or failed stability testing before its labeled expiry. Heat, moisture or time can break the drug down into degradants or reduce potency. All stability / shelf life recalls.

What was recalled

Alinia (nitazoxanide), powder for oral suspension, 100mg/5mL, 60 mL/bottle. Rx only, Manufactured for Lupin Pharmaceuticals Inc, Baltimore, Maryland 21202 for Romark Laboratories 3000 Bayport Dr. Suite 200, Tampa, FL 33607

Recalling firm
Romark Laboratories, L.C.
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0983-2015 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other stability / shelf life recalls from 2015

All stability / shelf life recalls
Class III · Low risk

Ranitidine Syrup

Failed Stability Specifications: Out of Specification results obtained for preservative butylparaben.

Terminated Stability / shelf life Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals D-0162-2016